Chik C L, Friedman A, Merriam G R, Gahl W A
National Institutes of Health, Bethesda, Maryland.
Ann Intern Med. 1993 Oct 1;119(7 Pt 1):568-75. doi: 10.7326/0003-4819-119-7_part_1-199310010-00004.
To evaluate reproductive function in patients with cystinosis and in renal transplant recipients without cystinosis.
Cross-sectional study.
Clinical Center, National Institutes of Health.
Ten male patients, 15 to 28 years old, with nephropathic cystinosis and renal allografts formed the study group; 11 renal transplant recipients who had a primary renal disorder other than cystinosis and were matched with study patients for age and renal function served as the control group.
Tanner staging, serum gonadotropin determinations, and testosterone and testosterone-binding globulin assessments. Selected patients also had a human chorionic gonadotropin (HCG) stimulation test, a gonadotropin-releasing hormone (GnRH) stimulation test, and serial sampling for luteinizing hormone (LH).
Although testosterone levels were within normal limits in 7 of 10 patients with cystinosis, the mean testosterone level in patients with cystinosis was 11.5 +/- 2.0 nmol/L compared with 24.2 +/- 3.0 nmol/L in control patients (P < 0.005). No patient with cystinosis reached Tanner stage 5 (full pubertal development), whereas 9 of 11 control patients did. Seven of 10 patients with cystinosis had elevations in LH or follicle-stimulating hormone (FSH) levels, suggesting testicular failure. These patients also had normal LH and FSH responses after GnRH stimulation, increased LH pulse frequency, and reduced testosterone response after HCG stimulation. In comparison, only 3 of 11 control patients had minimally elevated gonadotropin levels, and all 11 had normal testosterone levels. Microscopic testicular examination in one patient showed cystine crystals, germinal dysplasia, increased fibrosis, and Leydig cell hyperplasia.
Abnormalities in the pituitary-testicular axis are common in male patients with cystinosis. These changes appear to be related to the disease cystinosis and not to treated renal failure per se.
评估胱氨酸病患者及无胱氨酸病的肾移植受者的生殖功能。
横断面研究。
国立卫生研究院临床中心。
10名年龄在15至28岁之间的患有肾病性胱氨酸病并接受肾移植的男性患者组成研究组;11名患有除胱氨酸病之外的原发性肾脏疾病且在年龄和肾功能方面与研究患者相匹配的肾移植受者作为对照组。
坦纳分期、血清促性腺激素测定以及睾酮和睾酮结合球蛋白评估。部分患者还进行了人绒毛膜促性腺激素(HCG)刺激试验、促性腺激素释放激素(GnRH)刺激试验以及黄体生成素(LH)的系列采样。
虽然10名胱氨酸病患者中有7名的睾酮水平在正常范围内,但胱氨酸病患者的平均睾酮水平为11.5±2.0 nmol/L,而对照患者为24.2±3.0 nmol/L(P<0.005)。没有胱氨酸病患者达到坦纳5期(青春期完全发育),而11名对照患者中有9名达到。10名胱氨酸病患者中有7名的LH或促卵泡生成素(FSH)水平升高,提示睾丸功能衰竭。这些患者在GnRH刺激后LH和FSH反应正常,LH脉冲频率增加,HCG刺激后睾酮反应降低。相比之下,11名对照患者中只有3名促性腺激素水平略有升高,且所有11名患者的睾酮水平均正常。对一名患者的睾丸进行显微镜检查发现有胱氨酸结晶、生精发育异常、纤维化增加以及睾丸间质细胞增生。
垂体-睾丸轴异常在男性胱氨酸病患者中很常见。这些变化似乎与胱氨酸病本身有关,而非与治疗后的肾衰竭有关。